Release Date: December 13, 2022
Valid for Credit through: January 13, 2024
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.
This activity is supported by independent educational grants from
Biogen and Genentech.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — maximum of 1.0 contact hour(s) of nursing continuing professional development (NCPD)
- Pharmacists — maximum of 1.0 contact hour(s) of continuing pharmacy education credit
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice nurses, physician assistants, nurses, pharmacists, and other members of the healthcare professional team who care for people with MS.
Program Overview
An interactive, case-based activity designed to challenge learners’ thinking and decision-making skills, while providing evidence and expert insights related to considerations in the care of people living with MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss patient-specific considerations that affect decisions for initiating or switching treatment for patients with MS
- Review disease-modifying and symptomatic therapies for MS
- Identify socio-economic, geographic, and ethnocultural considerations in the care of people living with MS
Faculty
James Bowen, MD
Multiple Sclerosis Center, Swedish Neuroscience Institute
Le Hua, MD
Lou Ruvo Center for Brain Health
Cleveland Clinic
Physician Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Credit Designation
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The CMSC designates this activity for a maximum of 1.0 NCPD credit (1.0 in the area of pharmacology).
Pharmacists Credit Designation
This knowledge-based activity, UAN JA4008165-9999-22-038-H01-P, qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit.
All other healthcare professionals completing this course will be issued a statement of participation.
Contact Information
For questions about this activity, please contact Catamount Medical Education at [email protected].